XML 58 R43.htm IDEA: XBRL DOCUMENT v3.25.0.1

Stock-Based Compensation and Other Benefit Plans (Tables)

12 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Stock Options

Stock option activity for the years ended December 31, 2024 and 2023, was as follows:

			Shares						Weighted-Average Exercise Price						Weighted-Average Fair Value
Outstanding as of December 31, 2022			693,650
Granted			190,728						$	3.42					$	2.57
Exercised			—						$	—					$	—
Forfeited			(457,815)						$	7.10					$	7.28
Expired			(130,000)						$	7.97					$	5.94
Outstanding as of December 31, 2023			296,563
Granted			—						$	—					$	—
Exercised			—						$	—					$	—
Forfeited			(29,367)						$	6.58					$	4.49
Expired			(47,918)						$	5.46					$	5.47
Outstanding as of December 31, 2024			219,278
Vested or expected to vest at December 31, 2024			185,489

The below table shows the aggregate intrinsic value and weighted average remaining contractual term of share options outstanding, currently exercisable and vested or expected to vest.

			Share Options Outstanding						Share Options Currently Exercisable						Share Options Vested or Expected to Vest
Number			219,278						34,306						185,489
Weighted-average exercise price			$	3.91					$	6.49					$	3.97
Aggregate intrinsic value ($000’s)			$	1,230					$	102					$	1,029
Weighted-average remaining contractual term in years			8.12						4.64						8.03

Schedule of Valuation Assumptions

The following table sets forth significant assumptions used in the Monte Carlo model for market-based options to determine the fair value of the 61,984 options awarded in June 2023 at the date of grant.

									June 7, 2023 Awards
Risk-free interest rate									3.79		%
Expected volatility of common stock									110.00		%
Expected life of options in years									10.0
Dividend yield									—		%

The following table sets forth significant assumptions used in the Black-Scholes model for performance options to determine the fair value of the 128,744 options awarded in December 2023 at the date of grant.

									December 5, 2023 Awards
Risk-free interest rate									4.13		%
Expected volatility of common stock									90.60		%
Expected life of options in years									6.5
Dividend yield									—		%

The following table sets forth significant assumptions used in the Monte Carlo model to determine the grant date fair value of the 73,525 performance-based RSUs with a market-based vesting criteria awarded in 2024.

									October 30, 2024 Awards
Risk-free interest rate									4.20		%
Expected volatility of common stock									53.10		%
Expected life of RSU in years									1.2
Dividend yield									—		%

The key inputs to the Black-Scholes Model used to estimate the fair value of the vested equity awards, as of the date of the termination were as follows:

									January 19, 2023
Risk-free interest rate									3.79		%
Expected volatility of common stock									90.00		%
Expected life of options in years									6.92
Stock price (1)									$	1.37
Strike Price									$	1.93
(1)Stock price is based on the price of common shares prior to the Company’s 1-for-6 reverse stock split in September 2023.

Schedule of Restricted Stock Activity

RSA activity for the years ended December 31, 2024 and 2023, are as follows:

Restricted Stock Shares						Shares						Weighted- Average Fair Value at Date of Grant
Non-vested RSAs at December 31, 2022						384,534						$	8.23
Granted						146,204						$	4.52
Vested						(186,058)						$	7.81
Forfeited						(95,667)						$	9.25
Non-vested RSAs at December 31, 2023						249,013						$	5.97
Granted						93,760						$	4.43
Vested						(182,319)						$	5.47
Forfeited						(11,528)						$	7.77
Non-vested RSAs at December 31, 2024						148,926						$	5.46

Schedule of Restricted Stock Unit Activity

RSU activity for the years ended December 31, 2024 and 2023, was as follows:

Restricted Stock Units						Units						Weighted- Average Fair Value at Date of Grant
Non-vested RSUs at December 31, 2022						102,481						$	11.42
Granted						230,816						$	3.82
Vested						(82,730)						$	10.64
Forfeited						(38,000)						$	11.58
Non-vested RSUs at December 31, 2023						212,567						$	3.44
Granted						459,054						$	4.81
Vested						(71,476)						$	3.75
Forfeited						(48,098)						$	3.28
Non-vested RSUs at December 31, 2024						552,047						$	4.55

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration